HERCEPTIN

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug HERCEPTIN contains one active pharmaceutical ingredient (API):

1 Trastuzumab UNII P188ANX8CK - TRASTUZUMAB

Trastuzumab is a recombinant humanised IgG1 monoclonal antibody against the human epidermal growth factor receptor 2 (HER2). Τrastuzumab has been shown, in both in vitro assays and in animals, to inhibit the proliferation of human tumour cells that overexpress HER2. Read about Trastuzumab

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01FD01	Trastuzumab	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01F Monoclonal antibodies and antibody drug conjugates → L01FD HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
Discover more medicines within L01FD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10383L, 10391X, 10401K, 10402L, 10581X, 10588G, 10589H, 10597R, 10682F, 10743K, 10798H, 10803N, 10811B, 10817H, 4632T, 4639E, 4650R, 4703M, 7264H, 7265J, 7266K, 7267L
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 529202401154314, 529213020024503, 529216070026503
Country: CA	Health Products and Food Branch	Identifier(s): 02240692, 02480697
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 124-MBE-0318, 4-MBE-0214
Country: EE	Ravimiamet	Identifier(s): 1144516, 1624126
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 00145001, 100145002
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 460339, 573477
Country: FR	Base de données publique des médicaments	Identifier(s): 61276045, 62712079
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 231575, 48031
Country: HK	Department of Health Drug Office	Identifier(s): 50617, 50618, 56694, 62822, 64165
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4915, 7771
Country: JP	医薬品医療機器総合機構	Identifier(s): 4291406D5024, 4291406D6020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1010539, 1072551, 1075233
Country: NG	Registered Drug Product Database	Identifier(s): A6-0481
Country: NL	Z-Index G-Standaard	Identifier(s): 15666352, 15944174
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 107069, 57991
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 10481, 15622, 9003
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100099722, 100303915
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64381001, W64382001
Country: SG	Health Sciences Authority	Identifier(s): 11028P, 14867P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6993151H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699505772035, 8699505792330
Country: US	FDA, National Drug Code	Identifier(s): 50242-132
Country: ZA	Health Products Regulatory Authority	Identifier(s): 34/26/0419, 48/26/1244